Genpact Limited (G) Expected to Post Quarterly Sales of $685.59 Million
Brokerages predict that Genpact Limited (NYSE:G) will report sales of $685.59 million for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Genpact Limited’s earnings. The highest sales estimate is $689.89 million and the lowest is $682.14 million. Genpact Limited posted sales of $648.78 million in the same quarter last year, which suggests a positive year-over-year growth rate of 5.7%. The company is scheduled to report its next earnings results after the market closes on Tuesday, November 7th.
On average, analysts expect that Genpact Limited will report full-year sales of $685.59 million for the current fiscal year, with estimates ranging from $2.67 billion to $2.70 billion. For the next financial year, analysts anticipate that the business will report sales of $2.87 billion per share, with estimates ranging from $2.81 billion to $2.92 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Genpact Limited.
Genpact Limited (NYSE:G) last announced its quarterly earnings data on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. Genpact Limited had a net margin of 10.22% and a return on equity of 23.33%. The business had revenue of $670.70 million during the quarter, compared to analyst estimates of $642.68 million. During the same period last year, the firm posted $0.36 EPS. The company’s revenue was up 6.4% on a year-over-year basis.
G has been the subject of several research reports. Zacks Investment Research upgraded Genpact Limited from a “hold” rating to a “buy” rating and set a $33.00 price target for the company in a research report on Tuesday, August 8th. Wedbush reiterated an “outperform” rating and set a $33.00 price target on shares of Genpact Limited in a research report on Wednesday, August 9th. BidaskClub upgraded Genpact Limited from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, June 28th. Cantor Fitzgerald reiterated a “buy” rating and set a $32.00 price target on shares of Genpact Limited in a research report on Wednesday, September 13th. Finally, Cowen and Company reiterated an “outperform” rating and set a $33.00 price target (up from $30.00) on shares of Genpact Limited in a research report on Thursday, August 3rd. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Genpact Limited presently has a consensus rating of “Buy” and an average target price of $32.38.
In related news, major shareholder Bain Capital Investors Llc sold 8,498,874 shares of the stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total transaction of $244,087,661.28. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amit Chandra sold 275,508 shares of the stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total value of $7,912,589.76. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,358,442 shares of company stock worth $297,475,276. 1.41% of the stock is owned by corporate insiders.
Hedge funds have recently bought and sold shares of the business. YorkBridge Wealth Partners LLC raised its position in Genpact Limited by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock valued at $106,000 after purchasing an additional 189 shares in the last quarter. Acrospire Investment Management LLC raised its position in Genpact Limited by 569.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 4,019 shares of the business services provider’s stock valued at $112,000 after purchasing an additional 3,419 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Genpact Limited in the 1st quarter valued at about $110,000. Bronfman E.L. Rothschild L.P. raised its position in Genpact Limited by 1.9% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock valued at $141,000 after purchasing an additional 94 shares in the last quarter. Finally, BNP Paribas Arbitrage SA raised its position in Genpact Limited by 85.3% in the 1st quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock valued at $129,000 after purchasing an additional 2,403 shares in the last quarter. 92.16% of the stock is currently owned by institutional investors.
Genpact Limited (NYSE G) opened at 29.54 on Monday. The company has a 50 day moving average of $28.58 and a 200-day moving average of $27.32. Genpact Limited has a 12-month low of $22.62 and a 12-month high of $31.93. The stock has a market capitalization of $5.70 billion, a price-to-earnings ratio of 22.31 and a beta of 0.53.
The company also recently announced a special dividend, which was paid on Thursday, September 21st. Investors of record on Friday, September 8th were paid a dividend of $0.06 per share. This represents a yield of 0.84%. The ex-dividend date was Thursday, September 7th. Genpact Limited’s payout ratio is 18.05%.
About Genpact Limited
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related stocks with our FREE daily email newsletter.